Long-term Local Control and Cosmesis of Perioperative Interstitial Brachytherapy for Partial Breast Irradiation Following Breast-conserving Surgery

Overview

Journal Breast Cancer

Date 2025 Feb 5

PMID 39907906

Authors

Kazuhiko Sato

Hiromi Fuchikami

Naoko Takeda

Nana Natsume

Masahiro Kato

Affiliations

Soon will be listed here.

Abstract

Purpose: Multicatheter interstitial brachytherapy (MIB) is an established technique of partial breast irradiation (PBI). However, postoperative catheter implant is an invasive, inconvenient, and skillful procedure. In this study, local control and cosmesis of perioperative interstitial brachytherapy (PIB) by intraoperative catheter implant were evaluated by comparing with those of whole breast irradiation (WBI) following breast-conserving surgery (BCS).

Methods: Between October 2007 and August 2019, consequent patients who underwent either PIB or WBI following BCS were included. In general, additional indications for PIB to WBI included age ≥ 40 years, tumor ≤ 3 cm, and pN0 or pNmi. WBI was initiated with a total dose of 50 Gy in 25 fractions, whereas PBI was delivered immediately following BCS at 32 Gy in eight fractions. Local recurrence (LR) was the primary endpoint, and subjective and objective cosmetic outcomes at 5 years using the Harvard Cosmesis Scale and BCCT.core software, respectively, were the secondary endpoints.

Results: During the 10-year follow-up, the crude rate of LR was 3.8% (95% confidence interval [CI] 2.3-5.4) in 577 patients receiving PIB and 3.3% (95% CI 1.1-5.6) in 241 patients receiving WBI (P = 0.73). The 5- and 10-year LR-free survival rates in the PBI and WBI cohorts were 97.9% versus 97.9% and 95.4% versus 96.8%, respectively (P = 0.64). Multivariate analysis selected age < 50 years as an independent risk factor for LR. Excellent or good cosmesis in the PBI and WBI cohorts assessed by subjective and objective measures was 89.5% versus 84.5% (P = 0.26) and 83.7% versus 68.1% (P < 0.005), respectively.

Conclusions: Although this study was based on a retrospective chart review in a single institution, the largest series of data with a long follow-up suggested that acceptable local tumor control and cosmesis were achieved following PIB compared with WBI.

References

Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A . Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347(16):1227-32. DOI: 10.1056/NEJMoa020989. View

Fisher B, Anderson S, Bryant J, Margolese R, Deutsch M, Fisher E . Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347(16):1233-41. DOI: 10.1056/NEJMoa022152. View

Taylor C, Correa C, Duane F, Aznar M, Anderson S, Bergh J . Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials. J Clin Oncol. 2017; 35(15):1641-1649. PMC: 5548226. DOI: 10.1200/JCO.2016.72.0722. View

Meattini I, Guenzi M, Fozza A, Vidali C, Rovea P, Meacci F . Overview on cardiac, pulmonary and cutaneous toxicity in patients treated with adjuvant radiotherapy for breast cancer. Breast Cancer. 2016; 24(1):52-62. DOI: 10.1007/s12282-016-0694-3. View

Dragun A, Huang B, Tucker T, Spanos W . Disparities in the application of adjuvant radiotherapy after breast-conserving surgery for early stage breast cancer: impact on overall survival. Cancer. 2011; 117(12):2590-8. DOI: 10.1002/cncr.25821. View

Goyal S, Chandwani S, Haffty B, Demissie K . Effect of travel distance and time to radiotherapy on likelihood of receiving mastectomy. Ann Surg Oncol. 2014; 22(4):1095-101. PMC: 5361213. DOI: 10.1245/s10434-014-4093-8. View

Poortmans P, Arenas M, Livi L . Over-irradiation. Breast. 2016; 31:295-302. DOI: 10.1016/j.breast.2016.07.022. View

Hughes K, Schnaper L, R Bellon J, Cirrincione C, Berry D, McCormick B . Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013; 31(19):2382-7. PMC: 3691356. DOI: 10.1200/JCO.2012.45.2615. View

Kunkler I, Williams L, Jack W, Cameron D, Dixon J . Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol. 2015; 16(3):266-73. DOI: 10.1016/S1470-2045(14)71221-5. View

10.

Kunkler I, Williams L, Jack W, Cameron D, Dixon J . Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer. N Engl J Med. 2023; 388(7):585-594. DOI: 10.1056/NEJMoa2207586. View

11.

Shaitelman S, Anderson B, Arthur D, Bazan J, R Bellon J, Bradfield L . Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2023; 14(2):112-132. DOI: 10.1016/j.prro.2023.11.001. View

12.

Sato K, Shimo T, Fuchikami H, Takeda N, Kato M, Okawa T . Predicting adherence of dose-volume constraints for personalized partial-breast irradiation technique. Brachytherapy. 2020; 20(1):163-170. DOI: 10.1016/j.brachy.2020.06.018. View

13.

Cozzi S, Laplana M, Najjari D, Slocker A, Encinas X, Pera J . Advantages of intraoperative implant for interstitial brachytherapy for accelerated partial breast irradiation either frail patients with early-stage disease or in locally recurrent breast cancer. J Contemp Brachytherapy. 2018; 10(2):97-104. PMC: 5961524. DOI: 10.5114/jcb.2018.75594. View

14.

Sato K, Shimo T, Kato M, Natsume N, Fuchikami H, Takeda N . Computed tomography-guided partial-breast brachytherapy using implanted catheters as fiducial markers versus co-registered magnetic resonance imaging. Brachytherapy. 2021; 20(6):1219-1225. DOI: 10.1016/j.brachy.2021.08.007. View

15.

Sato K, Fuchikami H, Takeda N, Shimo T, Kato M, Okawa T . Moving incision for covert breast-conserving surgery may prevent early wound complications in brachytherapy-based partial-breast irradiation. Brachytherapy. 2019; 18(5):645-650. DOI: 10.1016/j.brachy.2019.05.002. View

16.

Sato K, Shimo T, Fuchikami H, Takeda N, Kato M, Okawa T . Catheter-based delineation of lumpectomy cavity for accurate target definition in partial-breast irradiation with multicatheter interstitial brachytherapy. J Contemp Brachytherapy. 2019; 11(2):108-115. PMC: 6536147. DOI: 10.5114/jcb.2019.84504. View

17.

Sato K, Fuchikami H, Takeda N, Shimo T, Kato M, Okawa T . Efficacy of Single-Plane Implant Technique in Partial Breast Brachytherapy in Small-Breasted Patients. Int J Radiat Oncol Biol Phys. 2019; 106(4):830-837. DOI: 10.1016/j.ijrobp.2019.11.024. View

18.

Kurtz J, Amalric R, BRANDONE H, AYME Y, Jacquemier J, Pietra J . Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer. 1989; 63(10):1912-7. DOI: 10.1002/1097-0142(19890515)63:10<1912::aid-cncr2820631007>3.0.co;2-y. View

19.

Harris J, LEVENE M, Svensson G, Hellman S . Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys. 1979; 5(2):257-61. DOI: 10.1016/0360-3016(79)90729-6. View

20.

Cardoso M, Cardoso J, Amaral N, Azevedo I, Barreau L, Bernardo M . Turning subjective into objective: the BCCT.core software for evaluation of cosmetic results in breast cancer conservative treatment. Breast. 2007; 16(5):456-61. DOI: 10.1016/j.breast.2007.05.002. View